Medine.co.uk

Vitbee 1000, 0.100% W/V Solution For Injection

Revised: 27 June 2008

AN: 02098/2007

1.

NAME OF THE VETERINARY MEDICINAL PRODUCT


Vitbee 1000, 0.100 % w/v Solution for Injection

2.

QUALITATIVE AND QUANTITATIVE COMPOSITION


Active substance

Qualitative composition

Cyanocobalamin

Excipients

Phenol


For a full list of excipients, see section 6.1.


Quantitative composition

0.100 % w/v


0.500 % w/v

3.

PHARMACEUTICAL FORM


Solution for injection.

A clear, red, sterile solution for injection.

4.

CLINICAL PARTICULARS

4.1

Target species


Cattle and horses, calves and foals.

4.2

Indications for use, specifying the target species


As an aid in raising Vitamin B12 levels in cattle and horses, calves and foals.


For use in the treatment of Vitamin B12 deficiency, and for poor growth rates and general unthriftiness in young animals when associated with the above deficiency.

4.3

Contraindications


Do not give by the intravenous route.

4.4

Special warnings for each target species


None known.

4.5

Special precautions for use

i.

Special precautions for use in animals


Observe normal aseptic precautions.

ii.

Special precautions for the person administering the veterinary medicinal product to animals


Care should be taken to avoid accidental self-injection or ingestion. In the case of accidental self-injection or ingestion, seek medical advice as a precautionary measure.

Following skin/eye contamination, wash/irrigate area thoroughly with cold water. Seek medical attention if irritation persists.

Wash hands after use.

4.6

Adverse reactions (frequency and seriousness)


None known.

4.7

Use during pregnancy, lactation or lay


Not contraindicated in pregnant or lactating animals.

4.8

Interaction with other medicinal products and other forms of interaction


None known.

4.9

Amount(s) to be administered and administration route


Cattle and horses 1-3 ml

Calves and foals 0.5-1 ml


By intra-muscular or subcutaneous injection.

Repeat in 7 days if required.

Following treatment, the vitamin B12 status of herbivores should be maintained by dietary supplementation with cobalt.

4.10

Overdose (symptoms, emergency procedures, antidotes), if necessary


Overdosage is unlikely.

4.11

Withdrawal period(s)


Meat: zero days.

Milk: zero hours.

5.

PHARMACOLOGICAL PROPERTIES



Pharmacotherapeutic group:



Cyanocobalamin


ATC Vet Code:


QB03BA01

5.1

Pharmacodynamic properties


B vitamins are not stored in the body to any great extent.

5.2

Pharmacokinetic properties


The metabolism of cyanocobalamin is complex and is associated closely with that of folic acid and of ascorbic acid. It is important for maintenance of normal haemopoiesis, protection of the liver, maintenance of muscle tissue, healthy skin, brain and pancreatic metabolism.


6.

PHARMACEUTICAL PARTICULARS

6.1

List of excipients


Phenol

Sodium acid phosphate dihydrate

Sodium chloride

Water for injections

6.2

Incompatibilities


None known.

6.3

Shelf life


Shelf life of the veterinary medicinal product as packaged for sale: 2 years.

Shelf life after first opening the immediate packaging: 28 days.

6.4

Special precautions for storage


Do not store above 25°C.

Protect from light.

6.5

Nature and composition of immediate packaging


50 ml type I amber glass vial, fitted with a red type I bung and aluminium overseal.

Secondary packaging: cardboard carton.

6.6

Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products, if appropriate


Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

7.

MARKETING AUTHORISATION HOLDER


Dechra Limited

Dechra House

Jamage Industrial Estate

Talke Pits

Stoke-on-Trent

Staffordshire

ST7 1XW

8.

MARKETING AUTHORISATION NUMBER


Vm 10434/4039


9.

DATE OF FIRST AUTHORISATION


26/02/1993


10.

DATE OF REVISION OF THE TEXT


27 June 2008